Literature DB >> 24554349

Electrocardiographic data quality in thorough QT/QTc studies.

Lars Johannesen1, Christine Garnett, Marek Malik.   

Abstract

BACKGROUND: Most drugs with systemic bioavailability have to undergo a thorough QT (TQT) study, which includes a pharmacologic positive control. A set of QTc-quality tests was recently proposed with the possible aim of removing the need for a positive control.
OBJECTIVE: We evaluated the influence of QT measurement and QTc computation methodology on the proposed QTc-quality tests.
METHODS: The baseline ECG waveforms and fiducial points were retrieved from 34 crossover TQT studies that had full-day baseline ECGs prior to each study period. The QT measurement methodology and recorder type were retrieved from study reports. The influence of QTc computation methodology was investigated by applying the pattern-matching technique and/or using the 10-s average heart rate.
RESULTS: There were no statistical differences in any QTc-quality test values between studies using continuous or 10-s bedside recordings and, in a subset of the quality test, an increase of data quality for semi-automatically read studies compared with those manually read (p < 0.01). There was a significant improvement (p < 0.01) in all the QTc-quality test values for QTc measurements obtained by using pattern matching with or without 10-s average heart rate in comparison to the original QTc measurements.
CONCLUSION: The findings suggest that QTc quality is mostly driven by the QTc measurement methodology rather than other study-related factors.

Entities:  

Mesh:

Year:  2014        PMID: 24554349     DOI: 10.1007/s40264-014-0140-4

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  8 in total

1.  Effect of number of replicate electrocardiograms recorded at each time point in a thorough QT study on sample size and study cost.

Authors:  Mili Natekar; Pooja Hingorani; Pallavi Gupta; Dilip R Karnad; Snehal Kothari; Michiel de Vries; Troy Zumbrunnen; Dhiraj Narula
Journal:  J Clin Pharmacol       Date:  2010-09-17       Impact factor: 3.126

2.  International Conference on Harmonisation; guidance on E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs; availability. Notice.

Authors: 
Journal:  Fed Regist       Date:  2005-10-20

3.  Systematic comparisons of electrocardiographic morphology increase the precision of QT interval measurement.

Authors:  Katerina Hnatkova; Peter Smetana; Ondrej Toman; Axel Bauer; Georg Schmidt; Marek Malik
Journal:  Pacing Clin Electrophysiol       Date:  2009-01       Impact factor: 1.976

4.  Automatic extraction of ECG strips from continuous 12-lead holter recordings for QT analysis at prescheduled versus optimized time points.

Authors:  Fabio Badilini; Martino Vaglio; Nenad Sarapa
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-01       Impact factor: 1.468

5.  Subject-specific profiles of QT/RR hysteresis.

Authors:  Marek Malik; Katerina Hnatkova; Tomas Novotny; Georg Schmidt
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-10       Impact factor: 4.733

6.  Assessing electrocardiographic data quality and possible replacement of pharmacologic positive control in thorough QT/QTc studies by investigations of drug-free QTc stability.

Authors:  Marek Malik; Joanne Zhang; Lars Johannesen; Katerina Hnatkova; Christine Garnett
Journal:  Heart Rhythm       Date:  2011-06-16       Impact factor: 6.343

7.  Pattern recognition analysis of digital ECGs: decreased QT measurement error and improved precision compared to semi-automated methods.

Authors:  Olivier Meyer; Georg Ferber; Gerard Greig; Henry H Holzgrefe
Journal:  J Electrocardiol       Date:  2012-12-22       Impact factor: 1.438

8.  Impact of electrocardiographic data quality on moxifloxacin response in thorough QT/QTc studies.

Authors:  Lars Johannesen; Christine Garnett; Marek Malik
Journal:  Drug Saf       Date:  2014-03       Impact factor: 5.606

  8 in total
  5 in total

1.  Implications of the IQ-CSRC Prospective Study: Time to Revise ICH E14.

Authors:  Borje Darpo; Christine Garnett; James Keirns; Norman Stockbridge
Journal:  Drug Saf       Date:  2015-09       Impact factor: 5.606

2.  Universal Correction for QT/RR Hysteresis.

Authors:  Marek Malik; Lars Johannesen; Katerina Hnatkova; Norman Stockbridge
Journal:  Drug Saf       Date:  2016-06       Impact factor: 5.606

3.  Importance of QT/RR hysteresis correction in studies of drug-induced QTc interval changes.

Authors:  Marek Malik; Christine Garnett; Katerina Hnatkova; Lars Johannesen; Jose Vicente; Norman Stockbridge
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-04-12       Impact factor: 2.745

Review 4.  Sources of QTc variability: Implications for effective ECG monitoring in clinical practice.

Authors:  Katerina Hnatkova; Marek Malik
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-11-24       Impact factor: 1.468

5.  Sex and race differences in J-Tend, J-Tpeak, and Tpeak-Tend intervals.

Authors:  Katerina Hnatkova; Ondřej Toman; Martina Šišáková; Peter Smetana; Katharina M Huster; Petra Barthel; Tomáš Novotný; Georg Schmidt; Marek Malik
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.